• 제목/요약/키워드: Pneumonia, Pneumococcal

검색결과 45건 처리시간 0.024초

농흉의 임상적 고찰110 (Clinical study of empyema thoracis: a review of 110 cases)

  • 최형호
    • Journal of Chest Surgery
    • /
    • 제16권4호
    • /
    • pp.533-538
    • /
    • 1983
  • The author made a clinical study of IIO cases of empyema thoracis who were diagnosed and treated at department of chest surgery, chosun university hospital, during the period of December 1979 through June 1983. 1. In age and sex distribution, 45 cases [41%] was under the age of 15 years, 65 cases [59%] was above the age of 15 years. The ratio of male to female was 2.6:1. 2. The predisposing factors were pneumonia 45 cases [41%] and pulmonary tuberculosis 40 cases [36.5%]. 3. The cardinal symptoms were dyspnea, chest pain, fever, cough in order. 4. Etiologic organisms were confirmed in 69% which requested in 87 cases. Staphylococcal infection were 19 cases, Streptococcal infection were 13 cases, pneumococcal infection were 11 cases. 5. In treatment of empyema, thoracentesis 4 cases, closed thoracotomy 50 cases, open drainage 29 cases, decortication 14 cases and thoracoplasty 13 cases. In children, only thoracentesis and closed thoracotomy was favorable result in treatment. 6. 103 cases were discharged with recovery and improvement but 7 cases were early discharged by their economic or personal condition without improved.

  • PDF

Optimization of Culture Conditions for Production of Pneumococcal Capsular Polysaccharide Type I

  • Kim, Su-Nam;Min, Kwan-Ki;Kim, Seung-Hwan;Choi, In-Hwa;Lee, Suhk-Hyung;Pyo, Suhk-Noung;Rhee, Dong-Kwon
    • Journal of Microbiology
    • /
    • 제34권2호
    • /
    • pp.179-183
    • /
    • 1996
  • Streptoccus Pneumoniae (pneumococcus), the most common cause of bacterial pneumonia, has an ample polysaccharide (PS) capsule that is highly antigenic and is the source of PS vaccine. This investigation was undertaken to optimize the culture conditions for the production of capsulard PS by type 1 pneumococcus. Among several culture media, brain heart infusion (BHI) and Casitone based media were found to support luxuriant growth of pneumococcus type 1 at the same level. Because BHI medium is rather expensive and more complex than the Casitone based media, the Casitone based media was uwed to study optimization of the culture condition. The phase of growth which accomodated maximum PS production was logarithmic phase. Concentrations of glucose greater than 0.2% did not ehnahce growth or PS production. Substitution of netrogen sources with other resources or supplementation of various concentrations of metal ion (with the exception of calcium ion) had adverse affects on growth and PS production. On the other hand, low level aeration was beneficial for increased PS production. Addition of 3 mg/1 concentration of methionine, phenylalanine, and threonine were found to enhance growth and PS production. The synerigistic effect of all the favorable conditions observed in pneumococcal growth assays provided a two-fold cummulative increase in capsular PS production.

  • PDF

Korean Red Ginseng enhances pneumococcal △pep27 vaccine efficacy by inhibiting reactive oxygen species production

  • Lee, Si-On;Lee, Seungyeop;Kim, Se-Jin;Rhee, Dong-Kwon
    • Journal of Ginseng Research
    • /
    • 제43권2호
    • /
    • pp.218-225
    • /
    • 2019
  • Background: Streptococcus pneumoniae, more than 90 serotypes of which exist, is recognized as an etiologic agent of pneumonia, meningitis, and sepsis associated with significant morbidity and mortality worldwide. Immunization with a pneumococcal pep27 mutant (${{\Delta}}pep27$) has been shown to confer comprehensive, long-term protection against even nontypeable strains. However, ${{\Delta}}pep27$ is effective as a vaccine only after at least three rounds of immunization. Therefore, treatments capable of enhancing the efficiency of ${{\Delta}}pep27$ immunization should be identified without delay. Panax ginseng Mayer has already been shown to have pharmacological and antioxidant effects. Here, the ability of Korean Red Ginseng (KRG) to enhance the efficacy of ${{\Delta}}pep27$ immunization was investigated. Methods: Mice were treated with KRG and immunized with ${{\Delta}}pep27$ before infection with the pathogenic S. pneumoniae strain D39. Total reactive oxygen species production was measured using lung homogenates, and inducible nitric oxide (NO) synthase and antiapoptotic protein expression was determined by immunoblotting. The phagocytic activity of peritoneal macrophages was also tested after KRG treatment. Results: Compared with the other treatments, KRG significantly increased survival rate after lethal challenge and resulted in faster bacterial clearance via increased phagocytosis. Moreover, KRG enhanced ${{\Delta}}pep27$ vaccine efficacy by inhibiting reactive oxygen species production, reducing extracellular signal-regulated kinase apoptosis signaling and inflammation. Conclusion: Taken together, our results suggest that KRG reduces the time required for immunization with the ${{\Delta}}pep27$ vaccine by enhancing its efficacy.

폐구균에 의한 괴사성 폐렴 후 합병한 비전형적 용혈성 요독 증후군 1례 (A Case of Hemolytic Uremic Syndrome Complicated by Pneumococcal Necrotizing Pneumonia)

  • 조은영;최영준;이선희;조희연;이진아;최은화;하일수;정해일;이환종;최용
    • Pediatric Infection and Vaccine
    • /
    • 제15권2호
    • /
    • pp.206-211
    • /
    • 2008
  • 소아 연령에서 침습성 질환의 가장 흔한 원인균인 폐구균은 드물게 용혈성 요독 증후군을 일으키는 원인이 되기도 하며, 심한 폐렴을 일으키는 경우 농흉이나 괴사성 폐렴을 합병하기도 한다. 저자들은 33개월 여자가 폐렴 및 흉막 삼출로 내원하여 용혈성 요독 증후군으로 진행하였고, 급성 호흡곤란증후군 및 괴사성 폐렴이 합병되었으며, 혈액 및 흉수배양검사상 혈청형 19A의 폐구균 감염이 확인된 1례를 경험하였다. 환아는 항생제, 복막투석과 인공호흡기 적용등의 치료를 받았으며, 약 2개월 간의 입원치료 후 신기능이 정상화되어 퇴원하였고, 5년간의 외래 추적관찰 결과 신장 계통의 합병증 및 폐기능의 이상 소견 없이 완전히 회복되었기에 보고하는 바이다.

  • PDF

농흉의 임상적 고찰64례 보고 (Clinical Study of Empyema Thoracis: a review of 64 cases)

  • 장정수;이종국
    • Journal of Chest Surgery
    • /
    • 제12권4호
    • /
    • pp.403-410
    • /
    • 1979
  • A Clinical analysis of 64 patients of thoracic empyema was done who received surgical intervention at Dept. of Thoracic Surgery of the Chosun University Hospital in the period of 3 years from September 1976 to October 1979. Following was the results: 1. Seven cases [10.9%] were under the age of 15 years, 16 cases [25%] was between 15-30 years and 41 cases [64.1%] was above the age of 30 years. A proportion of children and adult was 1:8. 2. Male and female ratio was 3:1. Right and left side pleural cavity ratio was 2.4:1. 3. Predisposing factors were pneumonia [35.9%] and pulmonary tuberculosis [28.1%]. 4. Most frequently encountered symptoms were dyspnea, cough, chest pain and fever in order. 5. Etiologic organisms were confirmed in 39 cases [86.7%] which requested in 45 cases. Staphylococcal infections were 11 cases and streptococcal, pneumococcal pseudomonas infection was infected in order. 6. Pneumothorax was associated with empyema on 21 cases [32.8%]; among those 13 cases [61.9%] were tuberculous in nature. 7. Sensitivity test was revealed that Minocin was most very sensitive drug, and next Erythromycin, Gentamycin and Penbrex in order. But most resistant drugs were Penicillin, Kanamycin, Streptomycin and Tetracycline in order. 8. Treatments were combined with antibiotics therapy and several surgical procedures for empyema. 26 cases [40.6%] were treated with closed thoracotomy drainage, 17 cases [26.6%] with open thoracotomy tube drainage and 9 cases decortication and 9 cases thoracoplasty. 9. 2 death cases occurred in 64 cases of thoracic empyema, and 79.7% cases were discharged with recovery and improvement.

  • PDF

폐렴구균 DNA 백신의 유효성 평가 (Evaluation of a Streptococcus pneumoniae DNA Vaccine Efficacy)

  • 이주희;한용문
    • 약학회지
    • /
    • 제49권6호
    • /
    • pp.484-489
    • /
    • 2005
  • Streptococcus pmeumoniae is the leading cause of pneumonia and bacterial meningitis. The current polysaccharide vaccine has been reported ineffective in elderly adults and children less than 2 years of age. Thus, in recent many researchers have been focused on a different approach, DNA vaccine. In our laboratory we developed a Streptococcus pneumoniae DNA (SPDNA) vaccine. This SPDNA vaccine was formulated by inserting the region encoding part of the capsule in the S. pneumoniae into the LAMP-1. In present work, with use of the SPDNA vaccine we attempted to establish a certain methodology useful for evaluation of effectiveness and immunoresponse of a DNA vaccine. Results showed that the subcutaneous route was the most effective for production of antisera specific for S. pneumoniae in mice. By isotyping analyses, IgM, IgGl, IgG2a, and IgG2b were determined. In addition, INF-$\gamma$ and IL-4 were predominantly detected. Combination of those data resulted in a pattern of IgGl < IgG2a=IgG2b and INF$\gamma\>$ >IL-4, which indicates the inmmunity towards the Thl response predominantly; furthermore, the SPDNA vaccination induced resistance of the CD4+T lymphocyte-depleted mice against disseminated pneumococcal infection. These data appear to be possibly due to activation of CDS8+T cell-activation. Taken together, this methodology can be applied for evaluating efficacy and mode of action of a DNA vaccine as minimum critera.

Clinical Characteristics of Community-Acquired Viridans Streptococcal Pneumonia

  • Choi, Sun Ha;Cha, Seung-Ick;Choi, Keum-Ju;Lim, Jae-Kwang;Seo, Hyewon;Yoo, Seung-Soo;Lee, Jaehee;Lee, Shin-Yup;Kim, Chang-Ho;Park, Jae-Yong
    • Tuberculosis and Respiratory Diseases
    • /
    • 제78권3호
    • /
    • pp.196-202
    • /
    • 2015
  • Background: Viridans streptococci (VS) are a large group of streptococcal bacteria that are causative agents of community-acquired respiratory tract infection. However, data regarding their clinical characteristics are limited. The purpose of the present study was to investigate the clinical and radiologic features of community-acquired pneumonia (CAP) with or without parapneumonic effusion caused by VS. Methods: Of 455 consecutive CAP patients with or without parapneumonic effusion, VS were isolated from the blood or pleural fluid in 27 (VS group, 5.9%) patients. Streptococcus pneumoniae was identified as a single etiologic agent in 70 (control group) patients. We compared various clinical parameters between the VS group and the control group. Results: In univariate analysis, the VS group was characterized by more frequent complicated parapneumonic effusion or empyema and bed-ridden status, lower incidences of productive cough, elevated procalcitonin (>0.5 ng/mL), lower age-adjusted Charlson comorbidity index score, and more frequent ground glass opacity (GGO) or consolidation on computed tomography (CT) scans. Multivariate analysis demonstrated that complicated parapneumonic effusion or empyema, productive cough, bed-ridden status, and GGO or consolidation on CT scans were independent predictors of community-acquired respiratory tract infection caused by VS. Conclusion: CAP caused by VS commonly presents as complicated parapneumonic effusion or empyema. It is characterized by less frequent productive cough, more frequent bed-ridden status, and less common CT pulmonary parenchymal lesions. However, its treatment outcome and clinical course are similar to those of pneumococcal pneumonia.

소아 침습성 폐구균 감염증의 역학적 특성과 임상 양상 (Epidemiology and Clinical Features of Invasive Pneumococcal Infections in Children)

  • 송은경;이준호;김남희;이진아;김동호;박기원;최은화;이환종
    • Pediatric Infection and Vaccine
    • /
    • 제12권2호
    • /
    • pp.140-148
    • /
    • 2005
  • 목 적 : 폐구균은 소아에서 침습성 감염을 일으키는 중요한 원인균의 하나이나 국내에는 소아 침습성 감염 양상에 대한 연구가 극히 제한되어 있다. 본 연구에서는 우리나라 소아에서 발생한 침습성 폐구균 감염증의 역학적 특성, 임상 양상, 사망률 등을 파악하고, 침습성 폐구균 감염증을 일으킨 균의 혈청형 및 항생제 감수성을 분석하고자 하였다. 방 법 : 1985년 10월부터 2003년 12월까지 19년간 서울대학교 어린이병원에서 미생물학적으로 확인된 침습성 폐구균 감염증으로 진단받았던 16세 이하의 환자 192명을 대상으로 후향적으로 의무 기록을 분석하였다. 분리된 모든 균주에 대하여 oxacillin disc 확산법으로 페니실린 감수성을 검사하였고 125균주에서 혈청형을 결정하였다. 결 과 : 19년간 192명의 환아에서 194례의 침습성 폐구균 감염이 확인되었으며, 면역기능 저하가 동반되지 않은 환자가 43%, 기저질환에 의한 면역 기능 저하가 동반된 환자가 57%였고, 20%가 병원 감염이었다. 면역 기능이 정상인 환자에서 균혈증이 27%, 수막염이 39%, 균혈증 또는 농흉이 동반된 폐렴이 26%, 봉와직염 등 연조직 감염이 4%, 골 및 관절의 감염이 4%였으며, 연령별로는 2세 이하가 60%, 2세에서 5세 이하가 27%, 5세 이상이 13%를 차지하였다. 기저 질환에 의한 면역 저하가 동반된 환자에서는 균혈증이 55%, 뇌수막염이 3%, 균혈증 또는 농흉이 동반된 폐렴이 16%, 복막염이 22%, 봉와직염 등 연조직 감염이 3%, 골 및 관절의 감염이 1%였으며, 연령별로는 2세 이하가 25%, 2세에서 5세 이하가 23%, 5세 이상이 52%를 차지하였다. 125균주의 혈청형을 분석하였고 이중 23F, 19F, 14, 6B, 6A, 9V, 19A형이 73%를 차지하였다. 사망률은 7%이었으며, 이중 면역저하가 동반된 경우가 62%였다. 전체적으로 페니실린 내성률은 65%였다. 결 론 : 폐구균은 소아에서 다양한 종류의 침습성 감염을 일으키며, 주로 봄에 많이 발생하였고, 면역 기능이 정상인 소아에서는 주로 5세 이하에서 발생하나 면역 기능 저하 환자에서는 연장아에서도 흔히 발생하였다. 7가 단백 결합백신에 포함된 혈청형은 66%(교차반응 포함 시 79%)였고, 최근 수년 사이에 페니실린 내성균주의 빈도는 90% 이상으로 매우 높았다.

  • PDF

소아에서 폐렴구균 집락률 측정을 위해 비인두 흡인 물의 총 RNA를 이용한 실시간 중합효소 연쇄반응법 (Real-time Reverse Transcription Polymerase Chain Reaction Using Total RNA Extracted from Nasopharyngeal Aspirates for Detection of Pneumococcal Carriage in Children)

  • 김영광;이경훈;윤기욱;이미경;임인석
    • Pediatric Infection and Vaccine
    • /
    • 제23권3호
    • /
    • pp.194-201
    • /
    • 2016
  • 목적: 폐렴구균은 주요 비인두 상재균으로, 주위 조직을 침범하여 침습성 감염을 일으킬 수 있어 보균율에 대한 감시가 중요하다. 본 연구에서는 임상에서 비인두 흡인물로부터 추출하고 남은 RNA를 이용하여 폐렴구균을 확인할 수 있는 실시간 중합효소 연쇄반응(real-time reverse transcription polymerase chain reaction [RT-PCR])법을 구축하고, 보균율 측정에 있어서의 정확성과 이점을 확인하고자 하였다. 방법: 2014년 9월부터 10월까지 중앙대학교병원에 입원하여 호흡기 바이러스 RT-PCR 검사를 시행받은 18세 이하의 소아들로부터 비인두 흡인물을 채취하였다. 먼저 배양법과 genomic DNA (gDNA)를 이용한 real-time PCR을 시행하여 폐렴구균 검출률의 정확성을 확인하였다. 이 중 처음 20개의 검체를 이용하여, 고전적인 배양법과 gDNA를 이용한 real-time PCR, 그리고 RNA를 이용한 real-time RT-PCR법을 시행하고 이를 비교 분석하였다. 결과: 총 157개의 검체에서 시행한 real-time PCR 검사는 기존의 배양검사와 일치율이 0.922 (P<0.01, Fisher exact test)로 매우 높았다. 배양검사에서 음성인 133개의 검체는 real-time PCR에서도 모두 음성을 보였다. 24개의 배양 양성 검체 중 21개의 검체는 real-time PCR에서도 양성이었지만, 나머지 검체는 음성 결과를 보였다. 20개의 검체에서 시행한 real-time RT-PCR 검사는 1개 검체를 제외하고 배양법 및 real-time PCR과 결과가 일치하였다. 한편, 배양법을 시행하고 결과를 확인하기까지는 총 26.5시간, real-time RT-PCR 검사에는 총 4.5시간이 소요되었다. 결론: 본 연구는 비인두 집락균 확인을 위한 real-time RT-PCR법의 확립과, 폐렴구균 보균율 측정에 있어서의 real-time RT-PCR 검사의 정확성 및 편의성을 보여주었다. Real-time RT-PCR 검사법은 주요 세균들의 보균율 연구에 있어서 시간과 노력을 줄일 수 있는 좋은 방법이며, 폐렴구균의 역학자료 수집에 큰 도움이 될 것으로 기대한다.

CLSI M40-A2 기준에 따른 수송배지의 흡수 및 배출, 생존 효율, 회수율 평가 (Evaluation of Absorption and Release, Survival Efficiency and Recovery Rate of Transport Medium according to the CLSI M40-A2 Standard)

  • 하성일;석현수;신정섭;허웅;박강균;박연준
    • 대한임상검사과학회지
    • /
    • 제51권2호
    • /
    • pp.164-170
    • /
    • 2019
  • 5종류의 수송배지를 흡수 및 배출 능력, 생존 효율, 회수율을 CLSI (Clinical and Laboratory Standards Institute) M40-A2의 Swab elution method (Quantitative) 기준으로 평가하였다. 액체배지가 반유동 배지보다 3가지 평가에서 대부분 우수한 결과값을 보여주었다. Flocked swab이 standard swab 형태보다 균의 흡수 및 배출의 능력 또한 우수하였다. 생존 효율에 대한 평가 결과는 액체배지(S4)가 가장 우수한 결과값을 보였다. 성장이 좋지 않은 S. pneumoniae는 액체배지(S4, S5)에서 생존효율과 회수율이 높았다. 균 회수율 평가 결과는 S. pyogenes는 모든 배지에서 CLSI 기준에 적합하였다. S. pneumoniae는 반유동 배지(S2, S3)에서 부적합하였고, 나머지 배지는 모두 기준에 적합하였다. H. influenzae는 반유동 배지(S1, S3)에서 부적합하였고, 반유동 배지(S2), 액체배지(S4, S5)에서 기준에 적합하였다. 호흡기 질환을 유발하는 S. pneumonia, H. influenzae의 생존 능력은 대부분의 배지에서 좋지 않았다. P. aeruginosa는 실온에서 과성장이 관찰되었다. 액체배지와 flocked swab의 조합이 3가지 평가 방법에서 가장 뛰어난 결과를 평가를 통해 확인하였다.